U.S. stocks traded slightly lower this morning, following the release of inflation data on Tuesday.
Following the market opening Tuesday, the Dow traded down 0.04% to 36,389.01 while the NASDAQ fell 0.18% to 14,406.14. The S&P 500 also fell, dropping, 0.27% to 4,610.13.
C4 Therapeutics Inc (NASDAQ: CCCC) has entered into an exclusive license and collaboration agreement with Merck & Co Inc (NYSE: MRK) to develop degrader-antibody conjugates (DACs), an emerging modality d
The Dow Jones index closed higher by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Shares of Icosavax, Inc. (NASDAQ: ICVX) rose sharply in pre-market trading after AstraZeneca announced plans to buy Icosavax in a deal valued at up to $1.1 billion.
Nokia Corp (NYSE: NOK) made several key announcements Tuesday, including cutting its financial outlook and sharing about a critical acquisition and a significant partnership.